SPOTLIGHT -
Dr Lindhiem is an associate professor of psychiatry at the University of Pittsburgh.
Issues in Regulating DTx
We need policies that make digital therapeutics accessible and acceptable to a broad patient audience. What barriers are there to reaching that goal?